|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV059496606 |
| 003 |
DE-627 |
| 005 |
20230625013539.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
221219s2022 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.pcd.2022.10.005
|2 doi
|
| 028 |
5 |
2 |
|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001965.pica
|
| 035 |
|
|
|a (DE-627)ELV059496606
|
| 035 |
|
|
|a (ELSEVIER)S1751-9918(22)00171-1
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 630
|q VZ
|
| 082 |
0 |
4 |
|a 640
|q VZ
|
| 082 |
0 |
4 |
|a 590
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 600
|q VZ
|
| 084 |
|
|
|a 50.70
|2 bkl
|
| 100 |
1 |
|
|a Franch-Nadal, Josep
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world
|
| 264 |
|
1 |
|c 2022
|
| 300 |
|
|
|a 8
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a To identify clinical predictors associated with a response in terms of glycemic control and weight loss in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).
|
| 650 |
|
7 |
|a eGFR
|2 Elsevier
|
| 650 |
|
7 |
|a FDA
|2 Elsevier
|
| 650 |
|
7 |
|a OR
|2 Elsevier
|
| 650 |
|
7 |
|a CI
|2 Elsevier
|
| 650 |
|
7 |
|a ITT
|2 Elsevier
|
| 650 |
|
7 |
|a SIDIAP
|2 Elsevier
|
| 650 |
|
7 |
|a EASD
|2 Elsevier
|
| 650 |
|
7 |
|a MPR
|2 Elsevier
|
| 650 |
|
7 |
|a RCTs
|2 Elsevier
|
| 650 |
|
7 |
|a GLP-1RAs
|2 Elsevier
|
| 650 |
|
7 |
|a ICS
|2 Elsevier
|
| 650 |
|
7 |
|a NIADs
|2 Elsevier
|
| 650 |
|
7 |
|a NICE
|2 Elsevier
|
| 650 |
|
7 |
|a DPP4i
|2 Elsevier
|
| 650 |
|
7 |
|a CKD-EPI
|2 Elsevier
|
| 650 |
|
7 |
|a HbA1c
|2 Elsevier
|
| 650 |
|
7 |
|a SGLT2i
|2 Elsevier
|
| 650 |
|
7 |
|a ADA
|2 Elsevier
|
| 650 |
|
7 |
|a BMI
|2 Elsevier
|
| 650 |
|
7 |
|a WHO
|2 Elsevier
|
| 700 |
1 |
|
|a Granado-Casas, Minerva
|4 oth
|
| 700 |
1 |
|
|a Mata-Cases, Manel
|4 oth
|
| 700 |
1 |
|
|a Ortega, Emilio
|4 oth
|
| 700 |
1 |
|
|a Vlacho, Bogdan
|4 oth
|
| 700 |
1 |
|
|a Mauricio, Didac
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier
|a David, Lauren A. ELSEVIER
|t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|d 2016
|g Amsterdam [u.a.]
|w (DE-627)ELV024210129
|
| 773 |
1 |
8 |
|g volume:16
|g year:2022
|g number:6
|g pages:810-817
|g extent:8
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.pcd.2022.10.005
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_227
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 50.70
|j Energie: Allgemeines
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 16
|j 2022
|e 6
|h 810-817
|g 8
|